Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in Israel

2008 ◽  
Vol 30 (11) ◽  
pp. 2167-2179 ◽  
Author(s):  
Gabriel Chodick ◽  
Varda Shalev ◽  
Yariv Gerber ◽  
Anthony D. Heymann ◽  
Haim Silber ◽  
...  
PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e49113 ◽  
Author(s):  
Pin-Liang Chen ◽  
Wei-Ju Lee ◽  
Wei-Zen Sun ◽  
Yen-Jen Oyang ◽  
Jong-Ling Fuh

PEDIATRICS ◽  
1999 ◽  
Vol 104 (Supplement_6) ◽  
pp. 1198-1203 ◽  
Author(s):  
Thomas B. Newman ◽  
Gabriel J. Escobar ◽  
Veronica M. Gonzales ◽  
Mary Anne Armstrong ◽  
Marla N. Gardner ◽  
...  

Objective. To determine the frequency and interhospital variation of bilirubin testing and identified hyperbilirubinemia in a large health maintenance organization. Design. Retrospective cohort study. Setting. Eleven Northern California Kaiser Permanente hospitals. Subjects. A total of 51 387 infants born in 1995–1996 at ≥36 weeks' gestation and ≥2000 g. Main Outcome Measure. Bilirubin tests and maximum bilirubin levels recorded in the first month after birth. Results. The proportion of infants receiving ≥1 bilirubin test varied across hospitals from 17% to 52%. The frequency of bilirubin levels ≥20 mg/dL (342 μmol/L) varied from .9% to 3.4% (mean: 2.0%), but was not associated with the frequency of bilirubin testing (R2 = .02). Maximum bilirubin levels ≥25 mg/dL (428 μmol/L) were identified in .15% of infants and levels ≥30 mg/dL (513 μmol/L) in .01%. Conclusions. Significant interhospital differences exist in bilirubin testing and frequency of identified hyperbilirubinemia. Bilirubin levels ≥20 mg/dL were commonly identified, but levels ≥25 mg/dL were not.


2020 ◽  
Vol 1 (1) ◽  
pp. 259-269
Author(s):  
Hua-Yin Hsu ◽  
Chia-Chi Hsieh ◽  
Yi-Chen Tseng ◽  
Chiu-Hsia Hung ◽  
Kow-Tong Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document